Product
Gardasil9
2 clinical trials
3 indications
Indication
Human PapillomavirusIndication
HPVIndication
vaccinationClinical trial
An Open-Label Clinical Trial Evaluating the Immunogenicity of the 9vHPV Vaccination 2-dose Regimen Over a Four-year Follow up Among Children 4 to 8 Years Old, An Exploratory Immunogenicity StudyStatus: Recruiting, Estimated PCD: 2028-04-01
Clinical trial
A Pilot Study of the Immunogenicity of a Two-dose Protocol for 9-valent Human Papilloma Virus Vaccination in Postpartum Girls and Women (15-45 Years Old) Previously Unvaccinated Against HPVStatus: Completed, Estimated PCD: 2022-07-01